Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000055

Options or other derivatives

  • Director acquired 32,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +32,500 32,500 D
Loading xslF345X05/wk-form4_1719000414.xml…